Fox Chase Cancer Center Adds Yun Shin Chun to Surgical Oncology Team
PHILADELPHIA (August 11, 2009) – Yun Shin Chun, MD, has joined Fox Chase Cancer Center as an attending surgeon in the department of surgical oncology. At Fox Chase, Chun treats patients with liver cancer, biliary tract cancer, pancreatic cancer, gastrointestinal cancers, and colorectal metastases to the liver. Her research interests include predicting an individual’s response to chemotherapy, the link between obesity and cancer, and quality of life after liver resection.
“My interest in cancer began in junior high when a mentor developed esophageal cancer, and I was struck by a feeling of powerlessness and ignorance,” says Chun. “Since then, I have endeavored to learn as much as possible about cancer and to empower patients with knowledge and confidence that they are being given the best treatment possible.”
Chun comes to Fox Chase from M.D. Anderson Cancer Center, where she was a clinical specialist in the department of surgical oncology and the department of critical care and where she completed her surgical oncology fellowship. In addition to the surgical oncology fellowship, Chun also completed a research fellowship at Memorial Sloan-Kettering Cancer Center and a general surgery internship and residency at Mayo Clinic.
“My work has contributed to our understanding and management of gastrointestinal cancers, especially of the liver, pancreas, and biliary tract,” Chun adds. “I wrote the first North American study on two-stage hepatectomy, which entails removing multiple tumors in the liver while ensuring that sufficient normal liver remains.”
Chun earned her MD from New York Medical College and BA from Harvard University. She is certified by the American Board of Surgery and is an active member of a number of medical organizations.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.